Statera Biopharma Inc (STAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2013 | 09-2013 | 06-2013 | 03-2013 | 12-2012 | |
| Sales | 3,872 | 1,636 | 1,613 | 1,368 | 2,162 |
| Gross Profit | 3,872 | 1,636 | 1,613 | 1,368 | 2,162 |
| Operating Expenses | 6,868 | 7,492 | 8,390 | 8,815 | 7,723 |
| Operating Income | -2,996 | -5,857 | -6,777 | -7,448 | -5,562 |
| Other Income | 2,151 | 1,246 | 2,890 | -3,340 | 7,768 |
| Pre-tax Income | -845 | -4,611 | -3,886 | -10,787 | 2,207 |
| Net Income Continuous | -845 | -4,611 | -3,886 | -10,787 | 2,207 |
| Minority Interests | -480 | -520 | -844 | -1,023 | -903 |
| Net Income | $-365 | $-4,091 | $-3,042 | $-9,764 | $3,110 |
| EPS Basic Total Ops | -0.07 | -1.80 | -1.40 | -4.40 | 2.05 |
| EPS Basic Continuous Ops | -0.36 | -2.05 | -1.73 | -4.81 | 1.77 |
| EPS Diluted Total Ops | -0.07 | -1.80 | -1.40 | -4.40 | 2.05 |
| EPS Diluted Continuous Ops | -0.36 | -2.05 | -1.73 | -4.81 | 1.77 |
| EBITDA(a) | $-2,809 | $-5,762 | $-6,682 | $-7,353 | $-5,459 |